Chronic GCPII (glutamate‐carboxypeptidase‐II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques is a research paper published in Alzheimer s & Dementia Translational Research & Clinical Interventions (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: P30 AG066508
NIA NIH HHS
Grant: P50 AG047270
NIA NIH HHS
Grant: R01 AG068130
NIDA NIH HHS
Grant: P30 DA018343
NIA NIH HHS
Grant: R01 AG062306
NIA NIH HHS
Grant: R01 AG061190
NIMH NIH HHS
Grant: R01 MH113257
NIGMS NIH HHS
Grant: T32 GM135083
National Institutes of Health
Grant: 5P30AG066508-03
Yale Alzheimer Disease Research Center
National Institutes of Health
Grant: 5R01AG068130-04
Development of GCPII inhibitors for the treatment of age-related cognitive disorders
National Institutes of Health
Grant: 5P50AG047270-03
Yale Alzheimer Disease Research Center
National Institutes of Health
Grant: 5R01MH113257-07
Yale Macaque Brain Resource
National Institutes of Health
Grant: 5P30DA018343-14
Yale/NIDA Neuroproteomics Center
National Institutes of Health
Grant: 1R01AG062306-01
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery Program
National Institutes of Health
Grant: 5R01AG061190-05
Preclinical assessment of GCPII inhibitors for cognition and tau pathology
FWCI
1.35
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals